Rare Disease Research Revenue and Competitors
Estimated Revenue & Valuation
- Rare Disease Research's estimated annual revenue is currently $7.1M per year.
- Rare Disease Research's estimated revenue per employee is $155,000
Employee Data
- Rare Disease Research has 46 Employees.
- Rare Disease Research grew their employee count by 24% last year.
Rare Disease Research's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Director Human Resources | Reveal Email/Phone |
4 | Director Clinical Operations, Principal Investigator | Reveal Email/Phone |
5 | Medical Director RDR-NC, Principal Investigator | Reveal Email/Phone |
6 | Director, Research Home Health | Reveal Email/Phone |
7 | Principal Investigator, Head Research | Reveal Email/Phone |
8 | Clinical Research Nurse | Reveal Email/Phone |
9 | Senior Clinical Research Coordinator/Research Educator | Reveal Email/Phone |
10 | Family Nurse Practitioner | Reveal Email/Phone |
Rare Disease Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $1.7M | 11 | -8% | N/A | N/A |
#3 | $2.3M | 15 | 50% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $17.1M | 110 | 5% | $0.07B | N/A |
#6 | $4M | 26 | -7% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $7.8M | 50 | 2% | N/A | N/A |
#10 | $1.7M | 11 | 10% | N/A | N/A |
What Is Rare Disease Research?
At Rare Disease Research, we aim to optimize the process of conducting clinical trials in rare disease conditions. To improve access to investigational therapies, increase opportunities for trial participation, patient recruitment and retention, we have an experienced team with multidisciplinary approach to orchestrate clinical research trials in rare disease conditions. We closely collaborate with sponsors, CRO, and patient advocacy groups to improve awareness and recruitment for cutting edge clinical trials. Because rare diseases are not often considered a public health matter, we tirelessly advocate for newborn screenings. We want to improve health outcome for infants with rare genetics conditions who otherwise would have to endure diagnosis odyssey and delayed treatment. Our newborn screening project for Spinal Muscular Atrophy will begin in 2018.
keywords:N/AN/A
Total Funding
46
Number of Employees
$7.1M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 46 | 7% | N/A |
#2 | $5.3M | 46 | 5% | N/A |
#3 | $5.3M | 46 | -16% | N/A |
#4 | $8.1M | 46 | -38% | N/A |
#5 | $3.5M | 46 | 0% | N/A |